SUMMARY Bone marrow erythroid progenitor cells were examined from 50 cases of acute leukaemia and from 20 normal subjects using an in vitro semisolid culture method. Numbers of both primitive erythroid progenitor cells (BFU-e) and later-stage erythroid progenitor cells (CFU-e) were remarkably depressed in patients with acute leukaemia in active phase. However, both BFU-e and CFU-e recovered to within normal range when the patients achieved remission. Peripheral blood BFU-e of children with acute lymphocytic leukaemia in remission were also examined and found to have values not significantly different from those of control subjects. There was no distinct correlation between the numbers of erythroid bursts or colonies and the duration of remission in patients with acute leukaemia in remission. The reduction of BFU-e and CFU-e in active acute leukaemia suggests the involvement of erythropoietic progenitors in the pathophysiology of this type of leukaemia.
In vitro culture of bone marrow cells has recently been applied to clinical studies, allowing the detection of early changes of haematopoietic progenitor cells in patients with various haematological diseases (Metcalf, 1977) . Many of these studies have exploited the technical advances made in the field of granulopoiesis (Moore, 1974) . For example, an examination of CFU-c (that is, the granulocytemacrophage progenitor) has led to the discovery of the early changes in the in vitro colony-forming pattern which sometimes predictably precedes clinical development of blastic crisis in patients with chronic myelogenous leukaemia (Moore, 1975) . Complementary techniques have now been developed which in turn have fostered studies of the red cell series. Erythropoietin-dependent, late-stage progenitor cells, that is, colony-forming uniterythroid (CFU-e) (Stephenson et al., 1971) , and more primitive early-stage progenitor cells, that is, burst-forming unit-erythroid (BFU-e), can now be quantitated using semisolid culture methods (Axelrad et al., 1974 ined (Mizoguchi et al., 1977; Tebbi and Gross, 1977) . In this communication we describe the growth and differentiating characteristics of erythroid progenitor cells (BFU-e and CFU-e) in patients with acute leukaemia and in normal subjects.
Patients and methods
From April to November 1977, adult patients with acute non-lymphocytic leukaemia (including acute myeloblastic leukaemia, acute monocytic leukaemia, acute promyelocytic leukaemia, acute myelomonocytic leukaemia, and acute forms of erythroleukaemia) were studied. Children (under 15 years at diagnosis) with acute lymphocytic leukaemia were also enrolled in this study. To ensure controlled studies of adult patients, healthy volunteers were recruited. For controlled studies of paediatric patients with acute lymphocytic leukaemia, children with non-haematological diseases but whose marrow had been examined during routine diagnostic procedures were chosen. All the children with acute lymphocytic leukaemia in remission were off chemotherapy at the time of examination.
REGULAR BFU-e AND CFU-e ASSAY Methylcellulose culture methodology, which was originally described by Iscove et al. (1974) , was used with slight modifications (Murphy and Sullivan, 1978 (Flow Labs No 240) , 1 % bovine serum albumin (Calbiochem, San Diego, California, USA), and 1 unit of human urinary erythropoietin (38 international units/mg) in a final volume of 1 ml in 35 x 10 mm Petri dishes (Lux Scientific Corporation, Newbury Park, California, USA). The erythropoietin was concentrated by Dr P. P. Dukes, of Childrens Hospital of Los Angeles, and distributed by the National Heart, Lung, and Blood Institute under grant HL-10880. These cell suspensions were then incubated at 37°C in 5% CO2 and 95% air with saturated humidity. After seven days' incubation, the numbers of erythrocytic colonies were counted, and on day 14 erythropoietic bursts were enumerated using an inverted microscope without staining. Reddish or red colonies, which had more than eight cells on day 7, were identified as erythroid colonies derived from CFU-e, and reddish or red bursts with macroscopic dimensions on day 14 were identified as erythropoietic bursts derived from BFU-e. The morphology of the cells was confirmed by cytocentrifugation and staining with Wright-Giemsa.
MINIATURISED ASSAY FOR ERYTHROID PROGENITORS
A small amount of peripheral blood was also taken from the paediatric patients, and the nucleated cells were cultured using the technology described previously, except that flat-bottomed microtitre plates (Cooke Laboratory Products, Alexandria, Virginia, USA) were used as a culture vessel (Urabe and Murphy, 1978) . In the presence of 1 unit of erythropoietin per ml 1-2 x 105 nucleated peripheral blood cells were plated in a final volume of 0-1 ml per microtitre well. Six microtitre wells were used for each BFU-e determination.
For statistical analysis, Student's t test was used.
Results
The number of colonies and bursts showed a dosedependency corresponding to the concentrations of cells as well as to erythropoietin. Microtitre plates used to grow erythropoietic bursts from peripheral blood showed reliability in terms of plating efficiency. This result was a function of different concentrations of cells as well as different concentrations of erythropoietin. Experiments in which identical cell suspensions were cultured using both regular 35 mm Petri dishes and microtitre plates simultaneously confirmed this observation (data not shown).
Peripheral blood BFU-e were assayed in 11 children with acute lymphocytic leukaemia in remission and in three paediatric controls. Mean number (± SE) of erythropoietic bursts of peripheral blood from children with acute lymphocytic leukaemia in remission was 3-5 ± 1-4 per 105 nucleated cells, which was not significantly different from control values (3-1 ± 0-5, SE, t test, P > 0-05).
Peripheral blood and bone marrow of children A. Urabe, M. J. Murphy, Jr, M. Haghbin, and T. S. Gee with acute lymphocytic leukaemia in remission were been studied extensively in patients with leukaemia examined at the same time. The observed correlation (Moore, 1974) . Moore et al. (1974) attempted to between the numbers of bursts from bone marrow reclassify acute leukaemia according to the culture and peripheral blood was r = 083, P < 0 001. findings of CFU-c, because the growth pattern of CFU-c correlated better with the patient's prognosis Discussion than conventional laboratory findings. It is of more interest that in some cases of chronic myelogenous Granulocyte-macrophage progenitors (CFU-c) have leukaemia, blastic crisis can be predicted using the agar culture results of CFU-c before the clinical signs of acute exacerbation appear (Moore, 1975) .
In our results in acute leukaemia reported here, primitive erythroid progenitors (BFU-e) showed changes comparable to the pattern of late-stage erythroid progenitors (CFU-e) in that both committed stem cells decreased during the active phase of disease and both recovered to within a normal range in remission. Tebbi and Gross (1977) reported that CFU-e in children with acute lymphocytic leukaemia in remission showed a significantly lower value than that of controls. However, each of their patients in remission was receiving chemotherapy at the time of examination (Dr Tebbi, personal communication). All our paediatric patients with acute lymphocytic leukaemia in remission were off chemotherapy, and the numbers of BFU-e and CFU-e for the majority of them revealed values within the normal range.
It is well accepted that BFU-e are closely related to the pluripotent stem cell (Iscove, 1977) . The fact that, in patients with acute leukaemia in active phase, the numbers of not only CFU-e but also BFU-e decreased concomitant with a reduction in the number of CFU-c of normal origin (Spitzer et al., 1978) suggests that haematopoietic stem cells are impaired in acute leukaemia, or at least erythropoietic progenitors are seriously suppressed by the leukaemic clone. Since most of the patients with acute leukaemia in remission reported here are still in remission, we are at present unable to comment on the possibility of prognostic prediction using erythroid assays. This information is currently being accumulated.
Peripheral blood BFU-e obtained using microtitre plates correlated with bone marrow BFU-e obtained by the regular method. This supports the usefulness of this miniaturised method for monitoring erythroid progenitors in some clinical cases where it is difficult to obtain an adequate number of cells for routine culture conditions (Urabe and Murphy, 1978 
